Federated Hermes, Inc. 13D and 13G filings for CASI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 10:48 am Sale |
2023-01-31 | 13G | CASI Pharmaceuticals, Inc. CASI |
FEDERATED HERMES INC. FHI |
661,070 4.860% |
-239,581 (-26.60%) |
Filing |
| 2023-02-01 10:39 am Purchase |
2022-12-31 | 13G | CASI Pharmaceuticals, Inc. CASI |
FEDERATED HERMES INC. FHI |
900,651 6.620% |
900,651 (New Position) |
Filing |